GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.410
+0.027 (7.16%)
At close: Nov 4, 2024, 4:00 PM
0.392
-0.018 (-4.44%)
Pre-market: Nov 5, 2024, 9:20 AM EST

GlycoMimetics Statistics

Total Valuation

GlycoMimetics has a market cap or net worth of $26.44 million. The enterprise value is $4.50 million.

Market Cap 26.44M
Enterprise Value 4.50M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

GlycoMimetics has 64.48 million shares outstanding. The number of shares has increased by 12.03% in one year.

Current Share Class 64.48M
Shares Outstanding 64.48M
Shares Change (YoY) +12.03%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 8.35%
Owned by Institutions (%) 12.12%
Float 44.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.32
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 450.11
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.02.

Current Ratio 5.48
Quick Ratio 5.16
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -104.49% and return on invested capital (ROIC) is -66.72%.

Return on Equity (ROE) -104.49%
Return on Assets (ROA) -59.25%
Return on Capital (ROIC) -66.72%
Revenue Per Employee $286
Profits Per Employee -$1.12M
Employee Count 35
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -69.63% in the last 52 weeks. The beta is 1.84, so GlycoMimetics's price volatility has been higher than the market average.

Beta (5Y) 1.84
52-Week Price Change -69.63%
50-Day Moving Average 0.19
200-Day Moving Average 1.14
Relative Strength Index (RSI) 72.13
Average Volume (20 Days) 60,302,220

Short Selling Information

The latest short interest is 1.83 million, so 2.83% of the outstanding shares have been sold short.

Short Interest 1.83M
Short Previous Month 1.64M
Short % of Shares Out 2.83%
Short % of Float 4.13%
Short Ratio (days to cover) 3.32

Income Statement

In the last 12 months, GlycoMimetics had revenue of $10,000 and -$39.11 million in losses. Loss per share was -$0.61.

Revenue 10,000
Gross Profit 10,000
Operating Income -40.88M
Pretax Income -39.11M
Net Income -39.11M
EBITDA -40.78M
EBIT -40.88M
Loss Per Share -$0.61
Full Income Statement

Balance Sheet

The company has $22.39 million in cash and $448,775 in debt, giving a net cash position of $21.94 million or $0.34 per share.

Cash & Cash Equivalents 22.39M
Total Debt 448,775
Net Cash 21.94M
Net Cash Per Share $0.34
Equity (Book Value) 20.06M
Book Value Per Share 0.31
Working Capital 19.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.70 million and capital expenditures -$18,639, giving a free cash flow of -$35.72 million.

Operating Cash Flow -35.70M
Capital Expenditures -18,639
Free Cash Flow -35.72M
FCF Per Share -$0.55
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -408,770.51%
Pretax Margin -391,132.31%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -357,190.33%

Dividends & Yields

GlycoMimetics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.03%
Shareholder Yield -12.03%
Earnings Yield -147.94%
FCF Yield -135.10%

Analyst Forecast

The average price target for GlycoMimetics is $12.00, which is 2,826.83% higher than the current price. The consensus rating is "Hold".

Price Target $12.00
Price Target Difference 2,826.83%
Analyst Consensus Hold
Analyst Count 3
Revenue Growth Forecast (5Y) 404.16%
EPS Growth Forecast (5Y) -24.51%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GlycoMimetics has an Altman Z-Score of -16.15 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.15
Piotroski F-Score 1